Seeking Rituximab 10 mg/mL (10 mL & 50 mL) for Peru Registration - DIGEMID Approved

Product enquiry

Published on

Dear Sir/Madam, We are currently seeking qualified manufacturers for the following Rituximab formulations intended for registration in Peru: Rituximab 10 mg/mL – 10 mL vial Rituximab 10 mg/mL – 50 mL vial If your company manufactures these products and your production facility is either approved by DIGEMID (Peru) or is prepared for a DIGEMID inspection, we would appreciate hearing from you. Additionally, we welcome you to share your product portfolio for international markets, particularly if dossiers are available in CTD format. Please feel free to reach out with relevant product and regulatory information at your earliest convenience. Best regards, -Prasanjit

Replies

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.